{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:12:57Z","timestamp":1783642377320,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06446-4","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:02:57Z","timestamp":1779069777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of radiolabeled 111In-albumin liposomes for long-term imaging of tumors"],"prefix":"10.1007","volume":"152","author":[{"given":"Mohammad","family":"Ahrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar Rahnama","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-4128","authenticated-orcid":false,"given":"Kayvan","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"6446_CR2","volume-title":"Comparison of dual radiolabeled liposomes (DRL), Tc-99m-DMP and GA-67 citrate for imaging osteomyelitis in rabbit model","author":"V Awasthi","year":"1997","unstructured":"Awasthi V, Goins B, Klipper R, Loredo R, Korvick D, Phillips W (1997) Comparison of dual radiolabeled liposomes (DRL), Tc-99m-DMP and GA-67 citrate for imaging osteomyelitis in rabbit model. JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC 1850 SAMUEL MORSE DR, RESTON, VA 20190\u2009\u2013\u20095316"},{"issue":"1\u20132","key":"6446_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0378-5173(02)00703-2","volume":"253","author":"V Awasthi","year":"2003","unstructured":"Awasthi V, Garcia D, Goins B, Phillips W (2003) Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharm 253(1\u20132):121\u2013132","journal-title":"Int J Pharm"},{"issue":"1","key":"6446_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41392-023-01366-y","volume":"8","author":"J-W Bai","year":"2023","unstructured":"Bai J-W, Qiu S-Q, Zhang G-J (2023) Molecular and functional imaging in cancer-targeted therapy: current applications and future directions. Signal Transduct Target Therapy 8(1):89","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"6446_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"YC Barenholz","year":"2012","unstructured":"Barenholz YC (2012) Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned. J Controlled Release 160(2):117\u2013134","journal-title":"J Controlled Release"},{"issue":"9","key":"6446_CR6","first-page":"1639","volume":"36","author":"OC Boerman","year":"1995","unstructured":"Boerman OC, Storm G, Oyen WJ, van Bloois L, van der Meer JW, Claessens RA, Crommelin DJ, Corstens FH (1995) Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med 36(9):1639\u20131644","journal-title":"J Nucl Med"},{"issue":"5","key":"6446_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0163-7827(00)00013-8","volume":"39","author":"O Boerman","year":"2000","unstructured":"Boerman O, Laverman P, Oyen W, Corstens F, Storm G (2000) Radiolabeled liposomes for scintigraphic imaging. Prog Lipid Res 39(5):461\u2013475","journal-title":"Prog Lipid Res"},{"issue":"6","key":"6446_CR7","first-page":"2111","volume":"29","author":"T-H Chow","year":"2009","unstructured":"Chow T-H, Lin Y-Y, Hwang J-J, Wang H-E, Tseng Y-L, Wang S-J, Liu R-S, Lin W-J, Yang C-S, Ting G (2009) Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29\/luc xenografted mouse model. Anticancer Res 29(6):2111\u20132120","journal-title":"Anticancer Res"},{"issue":"4","key":"6446_CR8","first-page":"622","volume":"41","author":"ETM Dams","year":"2000","unstructured":"Dams ETM, Oyen WJ, Boerman OC, Storm G, Laverman P, Kok PJ, Buijs WC, Bakker H, van der Meer JW, Corstens FH (2000) 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 41(4):622\u2013630","journal-title":"J Nucl Med"},{"key":"6446_CR9","doi-asserted-by":"crossref","unstructured":"De Silva L, Fu J-Y, Htar TT, Muniyandy S, Kasbollah A, W. H. B. Wan Kamal and L.-H., Chuah (2019) Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes. International journal of nanomedicine: 1101\u20131117","DOI":"10.2147\/IJN.S184912"},{"issue":"2","key":"6446_CR10","first-page":"152","volume":"51","author":"S Del Vecchio","year":"2007","unstructured":"Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M (2007) Nuclear imaging in cancer theranostics. Q J Nuclear Med Mol Imaging 51(2):152\u2013163","journal-title":"Q J Nuclear Med Mol Imaging"},{"key":"6446_CR11","doi-asserted-by":"crossref","unstructured":"Dillehay GL, Henkin R, Bova D, Dillehay G, Halama J, Karesh S, Wagner R, Zimmer A (2006) Nuclear medicine.","DOI":"10.2967\/jnumed.107.040329"},{"issue":"5","key":"6446_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/HP.0000000000000261","volume":"108","author":"V Drozdovitch","year":"2015","unstructured":"Drozdovitch V, Brill AB, Callahan RJ, Clanton JA, DePietro A, Goldsmith SJ, Greenspan BS, Gross MD, Hays MT, Moore SC (2015) Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960\u20132010. Health Phys 108(5):520\u2013537","journal-title":"Health Phys"},{"key":"6446_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","volume":"156","author":"N Filipczak","year":"2020","unstructured":"Filipczak N, Pan J, Yalamarty SSK, Torchilin VP (2020) Recent advancements in liposome technology. Adv Drug Deliv Rev 156:4\u201322","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"6446_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0163-7827(00)00014-X","volume":"40","author":"B Goins","year":"2001","unstructured":"Goins B, Phillips W (2001) The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog Lipid Res 40(1\u20132):95\u2013123","journal-title":"Prog Lipid Res"},{"issue":"6","key":"6446_CR15","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1148\/rg.2020200021","volume":"40","author":"JF Gomes Marin","year":"2020","unstructured":"Gomes Marin JF, Nunes RF, Coutinho AM, Zaniboni EC, Costa LB, Barbosa FG, Queiroz MA, Cerri GG, Buchpiguel CA (2020) Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology. Radiographics 40(6):1715\u20131740","journal-title":"Radiographics"},{"issue":"3","key":"6446_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discovery 2(3):214\u2013221","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"6446_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0378-5173(99)00256-2","volume":"190","author":"O Ishida","year":"1999","unstructured":"Ishida O, Maruyama K, Sasaki K, Iwatsuru M (1999) Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 190(1):49\u201356","journal-title":"Int J Pharm"},{"issue":"1","key":"6446_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0378-5173(91)90089-7","volume":"69","author":"M Jaggi","year":"1991","unstructured":"Jaggi M, Khar R, Chauhan U, Gangal S (1991) Liposomes as carriers of 99mTc glucoheptonate for liver imaging. Int J Pharm 69(1):77\u201379","journal-title":"Int J Pharm"},{"issue":"11","key":"6446_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat reviews Clin Oncol 7(11):653\u2013664","journal-title":"Nat reviews Clin Oncol"},{"issue":"24","key":"6446_CR20","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1039\/D1TB00126D","volume":"9","author":"A Jash","year":"2021","unstructured":"Jash A, Ubeyitogullari A, Rizvi SS (2021) Liposomes for oral delivery of protein and peptide-based therapeutics: Challenges, formulation strategies, and advances. J Mater Chem B 9(24):4773\u20134792","journal-title":"J Mater Chem B"},{"issue":"7","key":"6446_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2174\/1567201820666230621124953","volume":"21","author":"A Khajeei","year":"2024","unstructured":"Khajeei A, Masoomzadeh S, Gholikhani T, Javadzadeh Y (2024) The effect of PEGylation on drugs\u2019 pharmacokinetic parameters; from absorption to excretion. Curr Drug Deliv 21(7):978\u2013992","journal-title":"Curr Drug Deliv"},{"issue":"12","key":"6446_CR22","doi-asserted-by":"publisher","first-page":"10082","DOI":"10.3390\/ijms241210082","volume":"24","author":"J Kim","year":"2023","unstructured":"Kim J, Cho H, Lim D-K, Joo MK, Kim K (2023) Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors. Int J Mol Sci 24(12):10082","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6446_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/ijms18051079","volume":"18","author":"N Lamichhane","year":"2017","unstructured":"Lamichhane N, Dewkar GK, Sundaresan G, Mahon RN, Zweit J (2017) [18F]-fluorinated carboplatin and [111In]-liposome for image-guided drug delivery. Int J Mol Sci 18(5):1079","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6446_CR24","first-page":"620","volume":"20","author":"C-M Lee","year":"2005","unstructured":"Lee C-M, Choi Y, Huh EJ, Lee KY, Song H-C, Sun MJ, Jeong H-J, Cho C-S, Bom H-S (2005) Polyethylene glycol (PEG) modified 99mTc-HMPAOliposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation. Cancer Biother Radiopharm 20(6):620\u2013628","journal-title":"Cancer Biother Radiopharm"},{"issue":"9","key":"6446_CR25","first-page":"3798","volume":"28","author":"HY Low","year":"2023","unstructured":"Low HY, Yang C-T, Xia B, He T, Lam WWC, Ng DCE (2023) Radiolabeled Liposomes Nuclear Imaging Probes Molecules 28(9):3798","journal-title":"Radiolabeled Liposomes Nuclear Imaging Probes Molecules"},{"key":"6446_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.addr.2019.05.012","volume":"143","author":"F Man","year":"2019","unstructured":"Man F, Gawne PJ, de Rosales RT (2019) Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 143:134\u2013160","journal-title":"Adv Drug Deliv Rev"},{"key":"6446_CR27","doi-asserted-by":"crossref","unstructured":"Munekane M, Kosugi A, Yamasaki M, Watanabe Y, Kannaka K, Sano K, Yamasaki T, K.-i. Ogawara and, Mukai T (2022) Biodistribution study of indium-111-labeled PEGylated niosomes as novel drug carriers for tumor-targeting. Journal of Drug Delivery Science and Technology 75: 103648","DOI":"10.1016\/j.jddst.2022.103648"},{"issue":"1","key":"6446_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ijpharm.2015.08.048","volume":"495","author":"AR Nikpoor","year":"2015","unstructured":"Nikpoor AR, Tavakkol-Afshari J, Gholizadeh Z, Sadri K, Babaei MH, Chamani J, Badiee A, Jalali SA, Jaafari MR (2015) Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model. Int J Pharm 495(1):162\u2013170","journal-title":"Int J Pharm"},{"issue":"8","key":"6446_CR29","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.nano.2017.08.010","volume":"13","author":"AR Nikpoor","year":"2017","unstructured":"Nikpoor AR, Tavakkol-Afshari J, Sadri K, Jalali SA, Jaafari MR (2017) Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies. Nanomed Nanotechnol Biol Med 13(8):2671\u20132682","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"7","key":"6446_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0883-2897(92)90136-M","volume":"19","author":"I Ogihara-Umeda","year":"1992","unstructured":"Ogihara-Umeda I, Sasaki T, Nishigori H (1992) Development of a liposome-encapsulated radionuclide with preferential tumor accumulation\u2014the choice of radionuclide and chelating ligand. Int J Rad Appl Instrum 19(7):753\u2013757","journal-title":"Int J Rad Appl Instrum"},{"issue":"2","key":"6446_CR30","first-page":"326","volume":"37","author":"I Ogihara-Umeda","year":"1996","unstructured":"Ogihara-Umeda I, Sasaki T, Kojima S, Nishigori H (1996) Optimal radiolabeled liposomes for tumor imaging. J Nucl Med 37(2):326\u2013332","journal-title":"J Nucl Med"},{"key":"6446_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jconrel.2019.12.045","volume":"319","author":"J Owen","year":"2020","unstructured":"Owen J, Thomas E, Menon J, Gray M, Skaripa-Koukelli I, Gill MR, Wallington S, Miller RL, Vallis KA, Carlisle R (2020) Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation. J Controlled Release 319:222\u2013233","journal-title":"J Controlled Release"},{"issue":"4","key":"6446_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/107815529600200402","volume":"2","author":"J Patel","year":"1996","unstructured":"Patel J (1996) Liposomal doxorubicin: Doxil\u00ae. J Oncol Pharm Pract 2(4):201\u2013210","journal-title":"J Oncol Pharm Pract"},{"issue":"1\u20133","key":"6446_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0169-409X(98)00108-2","volume":"37","author":"WT Phillips","year":"1999","unstructured":"Phillips WT (1999) Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 37(1\u20133):13\u201332","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"6446_CR35","first-page":"69","volume":"1","author":"WT Phillips","year":"2009","unstructured":"Phillips WT, Goins BA, Bao A (2009) Radioactive liposomes Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol 1(1):69\u201383","journal-title":"Radioactive liposomes Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol"},{"issue":"5","key":"6446_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/1097-0142(19880901)62:5<905::AID-CNCR2820620509>3.0.CO;2-3","volume":"62","author":"CA Presant","year":"1988","unstructured":"Presant CA, Proffitt RT, Turner AF, Williams LE, Winsor D, Werner JL, Kennedy P, Wiseman C, Gala K, McKenna RJ (1988) Successful imaging of human cancer with indium-111\u2010labeled phospholipid vesicles. Cancer 62(5):905\u2013911","journal-title":"Cancer"},{"key":"6446_CR37","doi-asserted-by":"crossref","unstructured":"Raina N, Singh AK, Islam A (2021) Biological implications of polyethylene glycol and PEGylation: therapeutic approaches based on biophysical studies and protein structure-based drug design tools. Innovations and Implementations of Computer Aided Drug Discovery Strategies in Rational Drug Design: 273\u2013294","DOI":"10.1007\/978-981-15-8936-2_11"},{"issue":"12","key":"6446_CR38","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.2174\/0929867329666220929152644","volume":"30","author":"R Shen","year":"2023","unstructured":"Shen R, Yuan H (2023) Achievements and bottlenecks of PEGylation in nano-delivery systems. Curr Med Chem 30(12):1386\u20131405","journal-title":"Curr Med Chem"},{"key":"6446_CR39","first-page":"272","volume":"367","author":"H Shmeeda","year":"2003","unstructured":"Shmeeda H, Even-Chen S, Honen R, Cohen R, Weintraub C, Barenholz Y (2003) Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies. Elsevier 367:272\u2013292Methods in enzymology","journal-title":"Elsevier"},{"issue":"3","key":"6446_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/jpm13030389","volume":"13","author":"MA Subhan","year":"2023","unstructured":"Subhan MA, Parveen F, Filipczak N, Yalamarty SSK, Torchilin VP (2023) Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis. J personalized Med 13(3):389","journal-title":"J personalized Med"},{"key":"6446_CR41","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, Xiang J, Zhou Q, Piao Y, Tang J, Shao S, Zhou Z, Bae YH, Shen Y (2022) The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv Drug Deliv Rev 191:114614","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"6446_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","volume":"63","author":"V Torchilin","year":"2011","unstructured":"Torchilin V (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63(3):131\u2013135","journal-title":"Adv Drug Deliv Rev"},{"key":"6446_CR43","doi-asserted-by":"crossref","unstructured":"Tzror-Azankot C, Anaki A, Sadan T, Motiei M, Popovtzer R (2024) Surface radiolabeling of PEGylated liposomes for biomedical applications. Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XXI, SPIE","DOI":"10.1117\/12.3001812"},{"issue":"Supplement 2","key":"6446_CR44","doi-asserted-by":"publisher","first-page":"263S","DOI":"10.2967\/jnumed.120.254532","volume":"61","author":"WA Weber","year":"2020","unstructured":"Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM (2020) The future of nuclear medicine, molecular imaging, and theranostics. J Nucl Med 61(Supplement 2):263S\u2013272S","journal-title":"J Nucl Med"},{"key":"6446_CR45","doi-asserted-by":"publisher","first-page":"111203","DOI":"10.1016\/j.colsurfb.2020.111203","volume":"194","author":"JR Yazdi","year":"2020","unstructured":"Yazdi JR, Tafaghodi M, Sadri K, Mashreghi M, Nikpoor AR, Nikoofal-Sahlabadi S, Chamani J, Vakili R, Moosavian SA, Jaafari MR (2020) Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies. Colloids Surf B 194:111203","journal-title":"Colloids Surf B"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06446-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:14:19Z","timestamp":1783638859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06446-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["6446"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06446-4","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were conducted in accordance with the approval of Institutional Ethical Committee of Mashhad University of Medical Sciences in accordance with the principles of the Declaration of Helsinki. Consent to participate was not applicable as this study did not involve human subjects. (Master thesis code: 11130512942015).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable as this study did not include human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"133"}}